Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk AS    NOVO B   DK0060534915

NOVO NORDISK AS

(NOVO B)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M DKK Estimates in M DKK
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 111 780 111 696 111 831 119 590 126 897 136 014
EBITDA 51 625 52 149 51 173 56 488 59 924 65 294
Operating profit (EBIT) 48 432 48 967 47 248 51 957 55 195 59 719
Pre-Tax Profit (EBT) 47 798 48 680 47 615 49 183 55 041 59 873
Net income 37 925 38 130 38 628 38 961 43 544 47 303
P/E ratio 17,0x 21,7x 18,7x 19,7x 17,3x 15,7x
EPS ( DKK ) 15,0 15,4 15,9 16,3 18,6 20,4
Dividend per Share ( DKK ) 7,60 7,85 8,15 8,41 9,23 10,2
Yield 2,98% 2,35% 2,74% 2,62% 2,87% 3,18%
Reference price ( DKK ) 254,700 334,500 297,900 321,400 321,400 321,400
Announcement Date 02/02/2017
06:31am
02/01/2018
06:30am
02/01/2019
06:30am
- - -
Finances - Leverage
Actuals in M DKK Estimates in M DKK
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt - - - - - -
Finance 20 470 17 158 15 123 12 726 15 408 17 157
Operating income (EBITDA) 51 625 52 149 51 173 56 488 59 924 65 294
Leverage
(Debt/EBITDA)
- - - - - -
Capital Expenditure 7 061 8 679 9 524 9 169 8 079 7 718
Book Value Per Share (BVPS) ( DKK ) 18,1 20,4 21,5 23,0 26,5 30,2
Cash Flow per Share ( DKK ) 19,1 16,6 18,4 17,6 19,6 21,7
Announcement Date 02/02/2017
06:31am
02/01/2018
06:30am
02/01/2019
06:30am
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 762 319 M DKK -
Entreprise Value (EV) 749 592 M DKK 746 911 M DKK
Valuation 2019e 2020e
P/E ratio (Price / EPS) 19,7x 17,3x
Capitalization / Revenue 6,37x 6,01x
EV / Revenue 6,27x 5,91x
EV / EBITDA 13,3x 12,5x
Yield (DPS / Price) 2,62% 2,87%
Price to book (Price / BVPS) 14,0x 12,1x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 43,4% 43,5%
Operating Leverage (Delta EBIT / Delta Sales) 1,44x 1,02x
Net Margin (Net Profit / Revenue) 32,6% 34,3%
ROA (Net Profit / Asset) 34,1% 36,8%
ROE (Net Profit / Equities) 72,4% 73,7%
Rate of Dividend 51,5% 49,6%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   7,67% 6,37%
Cash Flow / Sales 34,9% 36,7%
Capital Intensity (Assets / Sales) 0,95x 0,93x
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend